Clearance-Modelle: Nichtkompartimentelle Modelle

Noncompartmental models estimate clearance using experimental data from a single drug dose without requiring compartmental assumptions. Unlike compartment models, this approach relies on rich sampling data and relates volume of distribution to systemic exposure and dosage, enabling robust clearance computation directly from observed concentration-time curves.

The observed area under the concentration-time curve (AUC) is calculated from time zero to the last detectable concentration using the trapezoidal rule. This value is then extrapolated to infinity to estimate total systemic exposure after a single drug dose, providing a key parameter for clearance determination.

In noncompartmental models, clearance depends on three primary factors: bioavailability, the administered drug dose, and the area under the concentration-time curve (AUC). These parameters work together to characterize how efficiently the body eliminates a drug without requiring assumptions about compartmental structure.

At steady state during intravenous infusion, the clearance formula incorporates a constant dosing rate and the steady-state concentration (Css). At this point, the amount of drug administered equals the amount eliminated over each dosing interval, creating a balance reflected in the modified clearance equation.

The noncompartmental approach uses rich, empirical sampling data collected directly after drug administration to calculate clearance. By relating observed volume of distribution to systemic exposure and dosage, it computes clearance robustly from actual experimental measurements rather than relying on theoretical compartmental models or distribution assumptions.

The area under the concentration-time curve (AUC) represents the total systemic exposure to a drug following a single dose administration. It integrates drug concentration over time and serves as a fundamental parameter in noncompartmental clearance calculations, reflecting how much drug circulates in the body throughout the dosing interval.

After calculating the observed AUC from time zero to the last detectable concentration using the trapezoidal rule, the noncompartmental approach extrapolates this value to infinity. This extrapolation accounts for drug elimination continuing beyond the final measurement point, ensuring complete estimation of systemic exposure for accurate clearance determination.